Nycomed Imaging As

Sterling Winthrop Inc.

Amersham Health As

Kenneth Robert Hollister

Robert A Snow

Paul Mark Henrichs

Gregory L McIntire

David L Ladd

Edward R Bacon

Pal Rongved

Daniel J Delecki

George C Na

Natarajan Rajagopalan

Vinay Chandrakant Desai

Wolfgang Hans Heinrich Gunther

Steven Blair Coffey

William Anthony Sanderson

Eric Paul Hohenschuh

Xin Peng

Dong Wei

Kenneth Edmund Keller

Marten Eriksen

Barbara O Yuan

The invention relates to a method of generating an image of an animate human or non-human animal body or part thereof. The method comprises administering to said body a physiologically tolerable contrast agent comprising a radiation absorbing component and/or a pressure inducing component, exposing said body to radiation, detecting pressure waves generated in said body by said radiation and generating an optoacoustic image therefrom of at least a part of said body containing the administered contrast agent.

Methods of photoacoustic imaging

This invention provides a physiologically tolerable light imaging contrast agent compound having a molecular weight in the range 500 to 5000000 and containing at least two chromophores having delocalized electron systems as well as at least one polyalkylene oxide (PAO) moiety having a molecular weight in the range 60 to 100000.

Compounds

The invention provides polymeric polychelants containing polymer repeat units of formula �L--Ch--L--B! (where Ch is a polydentate chelant moiety; L is an amide or ester linkage; B is a hydrophobic group providing a carbon chain of at least 4 carbon atoms between the L linkages it interconnects) or a salt or chelate thereof, with the proviso that where Ch is 2,5-biscarboxymethyl-2,5-diazahex-1,6-diyl, the polychelant is metallated with lanthanide or manganese ions or B provides a carbon chain of at least 10 carbon atoms between the L linkages it interconnects and their salts and chelates. The paramagnetic polychelates of the polychelants of the invention have remarkably high R.sub.1 relaxivities.

Polymeric contrast agents for medical imaging

This invention discloses a composition comprised of nanoparticles having a purified polymeric surfactant as a surface modifier adsorbed on the surface thereof and a cloud point modifier associated therewith, which cloud point modifier is present in an amount sufficient to increase the cloud point of the surface modifier. Preferred purified polymeric surfactants are purified polyalkyleneoxide substituted ethylenediamine surfactants. A preferred cloud point modifier is polyethylene glycol. This invention further discloses a method of making nanoparticles having a purified polymeric surfactant as a surface modifier adsorbed on the surface and a cloud point modifier associated therewith, comprised of contacting said nanoparticles with the cloud point modifier for a time and under conditions sufficient to increase the cloud point of the surface modifier.

Use of purified surface modifiers to prevent particle aggregation during

Growing community of inventors

Chester Springs, PA, United States of America

Kenneth Robert Hollister